BGLAIVE Trademark

Trademark Overview


On Wednesday, December 6, 2023, a trademark application was filed for BGLAIVE with the United States Patent and Trademark Office. The USPTO has given the BGLAIVE trademark a serial number of 79391412. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Wednesday, July 3, 2024. This trademark is owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOT. The BGLAIVE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-CD20 recombinant monoclonal antibody for medical use
bglaive

General Information


Serial Number79391412
Word MarkBGLAIVE
Filing DateWednesday, December 6, 2023
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateWednesday, July 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-CD20 recombinant monoclonal antibody for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOT
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Thursday, March 14, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, March 19, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 21, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 24, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, July 3, 2024ASSIGNED TO EXAMINER